ERGOMED is an established international clinical
development company offering contract clinical
research and co-development partnerships to biotechnology and pharmaceutical
companies
world wide.
ERGOMEDS's approach to
clinical
research ensures effective patient
recruitment reducing time and cost
of clinical trials.
Our expertise and depth
of experience in the clinical development process
complements the drug discovery and development capabilities
of our partners.
ERGOMED has a dual business
model offering standard clinical trial management
contracts and also co-development partnerships to
share the risk and rewards of clinical development.
October, 30, 2007 - ERGOMED locates regional headquarters at DuBiotech in Dubai. [read
more]
October, 22, 2007 -
ERGOMED opens new facility in Russia. Dr Sergei Drapkin appointed as Managing Director of Russian office. [read
more]
September, 10, 2007 - CeNeS and ERGOMED Report Start of Recruitment for Phase II trial of CNS 5161 in cancer pain. [read
more]